Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Singapore Medical Journal|September 20, 2021
Extrapulmonary manifestations and complications of severe acute respiratory syndrome coronavirus-2 infection: a systematic reviewJiacai Cho, Joanne Lee, Ching-Hui Sia, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 12, 2023
Etiologies, mechanisms, and risk factors of ischemic stroke in a young Asian adult cohortSarah Ml Tan, Jamie Sy Ho, Ching-Hui Sia, et al.
Thrombosis Research|May 23, 2025
Impact of mechanical pulmonary thrombectomy for intermediate-risk pulmonary embolism: Results from a prospective multicenter, multi-ethnic Asian registryTing Wei Teo, Sarah Ming Li Tan, Yun Yun Chiang, et al.
Hematology/Oncology and Stem Cell Therapy|April 30, 2018
Vinorelbine-Cyclophosphamide compared to cyclophosphamide in peripheral blood stem cell mobilization for multiple myelomaSanjay de Mel, Yunxin Chen, Adeline Lin, et al.
Nature Communications|November 26, 2021
Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitorsCho Yeow Koh, Norrapat Shih, Christina Y C Yip, et al.
Thrombosis Journal|March 9, 2021
Low incidence of venous thrombosis but high incidence of arterial thrombotic complications among critically ill COVID-19 patients in SingaporeChuen Wen Tan, Bingwen Eugene Fan, Winnie Z Y Teo, et al.
Cancers|April 3, 2021
Neutrophil-to-Lymphocyte Ratio Predicts Development of Immune-Related Adverse Events and Outcomes from Immune Checkpoint Blockade: A Case-Control StudyPei Yi Lee, Kellynn Qi Xuan Oen, Grace Rui Si Lim, et al.
The New England Journal of Medicine|March 13, 2024
Oral Iptacopan Monotherapy in Paroxysmal Nocturnal HemoglobinuriaRégis Peffault de Latour, Alexander Röth, Austin G Kulasekararaj, et al.
The Lancet. Haematology|May 30, 2025
Oral iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria: final 48-week results from the open-label, randomised, phase 3 APPLY-PNH trial in anti-C5-treated patients and the open-label, single-arm, phase 3 APPOINT-PNH trial in patients previously untreated with complement inhibitorsAntonio M Risitano, Austin G Kulasekararaj, Phillip Scheinberg, et al.
Pageof 5